The Southeast Asian country temporarily banned sales of some syrup-based medications in October after it identified the presence in some products of ethylene glycol and diethylene glycol as possible factors for causing the illness.
https://www.pharmalive.com/wp-content/uploads/2022/10/Reuterscoughsyrup10-20-2022.jpg8411200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-11-09 02:08:442022-11-09 10:10:30Indonesia suspends licenses of two more drug firms amid probe into child deaths
